Low Grade Upper Tract Urothelial Carcinoma
2 clinical trials · Condition
◉ Watch Low Grade Upper Tract Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma (NCT07265947) | Tyra Biosciences, Inc | 2025-12-22 |
| Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis (NCT06668493) | Ferring Pharmaceuticals | 2025-06-12 |
Track Low Grade Upper Tract Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.